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A corrigendum on
In utero therapy for congenital disorders
using amniotic fluid stem cells
by Ramachandra, D. L., Shaw, S. S. W.,
Shangaris, P., Loukogeorgakis, S., Guillot,
P. V., De Coppi, P., and David, A.
L. (2014). Front. Pharmacol. 5:270. doi:
10.3389/fphar.2014.00270
I am writing this manuscript to correct
the second author information. My name
is correctly spelt, S.W. Steven Shaw. But
“S.W. Steven” is the first name, “Shaw”
is the last name. My publications are
always searched by “Shaw SW” in pubmed.
However, in this article, my name is
searched by “Shaw SS.”
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